Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors
Sergei Doulatov(Ontario Institute for Cancer Research), George Q. Daley(Boston Children's Hospital), Melissa A. Kinney(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Elizabeth R. Macari(Boston Children's Hospital), Blanche P. Alter(National Institutes of Health), Hsiang‐Ying Lee(Kaohsiung Medical University), Alan H. Beggs(Boston Children's Hospital), Thorsten M. Schlaeger(Boston Children's Hospital), Suneet Agarwal(Harvard University), Manav Gupta(Boston Children's Hospital), Colin A. Sieff(Harvard University), Jessica Barragan(Boston Children's Hospital), Jessica M. Humphries(Boston Children's Hospital), Katherine McGrath(Boston Children's Hospital), Benjamin L. Ebert(Dana-Farber Cancer Institute), Anupama Narla(Stanford University), Linda T. Vo(University of California, San Francisco), Alison M. Taylor(Broad Institute), Harvey F. Lodish(Whitehead Institute for Biomedical Research), Leonard I. Zon(Harvard University Press), Lara Wahlster(Broad Institute), Hanna T. Gazda(Boston Children's Hospital), Alexander L. DeVine(Boston Children's Hospital)
Cited by 106
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k